Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units [Phase 2]

View source ↗

Summary

Phase 2 trial update for STOP-MSU evaluating tranexamic acid to stop haemorrhage in hyperacute intracerebral haemorrhage with mobile stroke units; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Neuroscience Trials Australia | Conditions: Intracerebral Haemorrhage | Phase 2 | Status: COMPLETED